The Medinol Group’s strategy centers around transforming an idea into a medical product which necessitates a distinctive range of in-house capabilities that facilitate its development at every stage.
Medinol Group’s R&D team is diverse and capable of supporting various knowledge areas including exotic metals, drugs, and polymers, as well as the development of unique medical device manufacturing equipment.
Medinol Group’s Clinical Department successfully conducts global clinical trials, advancing medicine and providing state-of-the-art treatments with commitment to patient safety.
The Clinical Department at Medinol has been at the forefront of medical research for over two decades. With numerous successful clinical trials, our department has played a significant role in advancing the field of medicine.
Our clinical expertise spans various disciplines including coronary vascular, endovascular, and structural heart, enabling us to provide state-of-the-art treatments to patients.
We take pride in our global reach, having conducted trials in multiple regions such as the USA, Europe, Japan, Israel and Brazil with thousands of patients benefitting from our research. Our highly skilled team of professionals is dedicated to advancing the boundaries of medical knowledge with a commitment to patient safety throughout all clinical trials.
Medinol Group’s Quality Management System ensures our coronary stents meet the highest safety, efficacy, and reliability standards, using a risk-based approach to proactively address issues and continuously improve.
As a developer and manufacturer of coronary stents, Medinol’s advanced Quality Management System is critical in ensuring that our products meet the highest standards of safety, efficacy, and reliability.
The quality management system is designed to comply with the most stringent regulatory requirements and it covers every aspect of the product development and manufacturing processes, from design and testing to the finished product and post-market surveillance.
In the Medinol Group, the Regulatory Affairs department is tasked with ensuring adherence to relevant global regulatory standards.
In the Medinol Group, we recognize the importance of complying with current regulatory requirements to ensure the safety and efficacy of our medical devices for patients. To fulfill this obligation, we are dedicated to keeping abreast of the most recent regulations and guidelines.
Our Regulatory Affairs division has substantial expertise in registering medical devices in different geographic zones such as:
With a focus on quality and innovation, we are dedicated to advancing the field of stent manufacturing and improving patient outcomes.
Medinol Group designs and manufactures high-quality stents using innovative techniques and materials to improve patient outcomes. Our expert team provides customized solutions that meet customer needs.
At Medinol, we specialize in designing and manufacturing high-quality stents for the medical industry.